CJC-1295 + Ipamorelin 5 mg + 5 mgVerpakking van 10 flacons6 op voorraadBespaar 22%
Uitgelichtpeptideintermediate6 op voorraad

CJC-1295 + Ipamorelin 5 mg + 5 mg

Klassieke GHRH + ghreline-mimeticumcombinatie

CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.

Dosis
5mg + 5mg / flacon
Vorm
Gelyofiliseerd poeder
Verpakking
Verpakking van 10 flacons

Uitsluitend voor onderzoeksdoeleinden. Deze verbinding wordt strikt verkocht voor in-vitro-onderzoek en laboratoriumdoeleinden en is niet bestemd voor menselijke consumptie of therapeutisch gebruik. Door te kopen bevestigt u dat u een gekwalificeerde onderzoeker bent en gaat u akkoord met onze volledige disclaimer.

€ 186 EUR
Bespaar 22%
Verpakking van 10 flacons
Was € 238 EUR
Verkocht als verpakking van 10 flacons

Nog maar 6 verpakkingen

🧪Laboratoriumgeverifieerd
✓Getest door derden
⚡Snelle wereldwijde verzending
🔒Veilige kaartbetaling
Overzicht

Gecombineerd onderzoeksflacon dat het GHRH-analoog CJC-1295 koppelt aan het selectieve ghreline-mimeticum Ipamorelin. De meest bestudeerde GH-secretagoogcombinatie met dubbel mechanisme in peptideonderzoek.

CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.

Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.

Mechanisme

CJC-1295 ondersteunt basale GHRH-receptorsignalering, terwijl Ipamorelin selectieve ghreline-receptorpulsen aandrijft. Onderzoek suggereert synergetische, naturalistische GH-afgiftepatronen bij onderzoeksproefpersonen.

Laboratoriumrapport

HPLC-geverifieerd tegen een zuiverheidsspecificatie van ≥99 %. Onafhankelijk getest door geaccrediteerde derdenlaboratoria.

CJC-1295: DAC vs no-DAC

CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.

FAQ voor onderzoekers

CJC-1295 + Ipamorelin — veelgestelde vragen

What is the CJC-1295 + Ipamorelin stack?

It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.

How does CJC-1295 differ from Ipamorelin?

CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.

Is CJC-1295 + Ipamorelin legal in Australia?

Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.

What does selective mean for Ipamorelin?

Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.

What is the typical CJC-1295 + Ipamorelin research dosage?

Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

Are CJC-1295 and Ipamorelin used together?

Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.

Verder lezen

Gidsen over CJC-1295 + Ipamorelin

Gerelateerde verbindingen

Onderzoekers bekijken ook

Melanotan IIUitgelichtVerpakking van 10 flaconsBespaar 22%

Melanotan II

Gelyofiliseerd poeder

10 mg

α-MSH-analoog onderzoekspeptide

€ 112 EUR
Bespaar 22%
Verpakking van 10 flacons
Was € 144 EUR
Details bekijken →